Vyne Therapeutics Inc (VYNE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
19,069,500
EV to revenue ratio (TTM)
10.04
EV to ebitda
1.84
Financial Performance
Revenue (TTM)
454,000
Gross profit (TTM)
454,000
EBITDA
-24,345,000
Profitability
Operating margin (TTM)
-4,437.00%
Profit margin
0.00%
Return on assets (TTM)
-37.00%
Return on equity (TTM)
-63.20%
Per Share Metrics
Revenue per share (TTM)
0.53
EPS
-27.58
Diluted EPS (TTM)
-27.58
Book value
36.93
Dividend per share
0
Dividend yield
0.00%
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
42
Price to book ratio (TTM)
0.755
Growth
Quarterly earnings growth (YoY)
-57.40%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.006